Ottawa-based cannabis investment firm CannaRoyalty Corp. (CSE:CRZ) says it’s acquiring a 20 per cent stake in Anandia Laboratories Inc., a company that specializes in marijuana testing, in a deal valued at $4 million.
There are currently seven licensed cannabis producers in Canada who are working with the Vancouver-based cannabis biotechnology company to test their products.
A report released last month by the federally appointed task force on marijuana highlighted the importance of testing cannabis products to ensure they’re safe for consumption.
OBJ360 (Sponsored)
Upgrading tech without the price tag: How one Ottawa company is changing the game
They say, “If it ain’t broke, don’t fix it.” But what if it’s outdated? Keeping up with the latest technologies can be a challenge when the pace of innovation is
ExecHealth brings Canada’s leading advanced longevity program to National Capital Region
Ottawa’s ExecHealth was one of the first private clinics in Canada to provide personalized, ongoing primary care, having opened its doors 20 years ago this year. Now the pioneering local
In addition to testing, Anandia Labs also develops cannabis strains for medical use.
The deal, which will be funded through a combination of cash, equipment and services and common shares, is expected to close by Jan. 31, subject to approvals.
CannaRoyalty, or Cannabis Royalties, finances and invests in marijuana companies in Canada and in American states that have legalized the substance.
CEO Mark Lustig told OBJ last month that many cannabis entrepreneurs in North America have great ideas, but are inexperienced in raising capital.
He also sees banks avoiding the risks of the industry, unwilling to dive into the market until they’re sure the majority of investment conditions and risk calculations fall in their favour.
This has created an opening for CannaRoyalty, which is financing and acquiring equity in promising companies in return for ownership, royalties or licensing agreements.
